Akèy › Pemfigis
Etid klinik pou Pemfigis ap rekrite nan Etazini
6 etid pou Pemfigis ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
Pa eta
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
Ap rekriteFaz 1
Laj 18 a 85 · Tout sèks · Mizajou Jul 22, 2026 · NCT06371417A Study to Investigate Safety and Efficacy of KB111 for the Treatment of Hailey-Hailey Disease
Ap rekriteFaz 1 bonè
Laj 12 ak plis · Tout sèks · Mizajou Jul 21, 2026 · NCT07717346Efficacy of Guselkumab in Treating Hailey Hailey Disease
Ap rekriteFaz 2Volontè an sante akeyi
Laj 18 a 90 · Tout sèks · Mizajou Jun 22, 2026 · NCT06651489A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou May 29, 2026 · NCT04422912Autoimmune Blistering Diseases Study
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Mar 30, 2026 · NCT02753777Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases.
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2024 · NCT06581562Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.